Cerebrolysin vs Creatine for memory
Short answer: For memory, users rate them about the same: 97% report improvement with Cerebrolysin (31 reports) and 93% with Creatine (85 reports).
Cerebrolysin has 30 meta-analyses and 60 randomized trials on PubMed; Creatine has 763 and 2,794.
Based on 228 reports about Cerebrolysin and 2,279 about Creatine. Not medical advice.
| Cerebrolysin Peptide | Creatine Supplement | |
|---|---|---|
| User score | 47 | 54 |
| Verdict | Mostly positive | Mostly positive |
| Positive of reports that state an outcome | 73% | 72% |
| Reports | 228 | 2,279 |
| Research | AResearch: Strong | AResearch: Strong |
| Meta-analyses / RCTs | 30 / 60 | 763 / 2,794 |
| Mainly used for | ||
| Weight loss % reporting improvement | — | 77% (31) |
| Appetite % reporting improvement | — | 67% (3) |
| Focus % reporting improvement | 92% (24) | 93% (249) |
| Energy % reporting improvement | 89% (9) | 97% (268) |
| Sleep % reporting improvement | 100% (5) | 28% (81) |
| Anxiety % reporting improvement | 89% (9) | 64% (25) |
| Mood % reporting improvement | 90% (20) | 87% (125) |
| Memory % reporting improvement | 97% (31) | 93% (85) |
| Performance % reporting improvement | — | 98% (542) |
| Recovery % reporting improvement | 100% (3) | 98% (95) |
| Pain & inflammation % reporting improvement | 100% (2) | 60% (5) |
| Digestion % reporting improvement | — | 0% (7) |
| Libido % reporting improvement | — | 82% (11) |
| Hormones % reporting improvement | — | 79% (19) |
| Blood sugar % reporting improvement | — | 100% (5) |
| Heart & lipids % reporting improvement | — | 71% (7) |
| Skin & hair % reporting improvement | — | 17% (12) |
| Immunity % reporting improvement | — | 100% (2) |
| Longevity % reporting improvement | — | 100% (4) |
| Common side effects | brain fog, fatigue, headache, tingling | stomach issues, hair loss, insomnia, water retention |
| Typical dose reported | Not listed | daily |
Ginkgo biloba extracts have shown the greatest cognitive and functional benefits, though their clinical significance remains uncertain, and certainty of evidence is overall low. Future trials should focus on a single VCI subtype, prioritize interventions with a strong mechanistic rationale, standardize diagnostic criteria, ensure adequate power for chosen outcomes, test against placebo, and implement FAIR data sharing to accelerate therapeutic discovery.
Alzheimers Dement, 2025 ↗“Cerebrolysin is by far the best nootropic I have ever used...my memory, recall ability, sensitivity to music, observance over my emotions, thinking faculties have all improved to a noticeable amount.”
The results of the meta-analysis suggest that creatine supplementation did not significantly alter serum creatinine levels (standardized mean difference = 0.48, 95% confidence interval 0.24-0.73, P = .001, I2 = 22%), and did not alter plasma urea values (standardized mean difference = 1.10, 95% confidence interval 0.34-1.85, P = .004, I2 = 28%). The findings indicate that creatine supplementation does not induce renal damage in the studied amounts and durations.
J Ren Nutr, 2019 ↗“I actually feel a lot better. Mentally clearer and more balanced, like I have my brain back.”
Related comparisons
Percentages come from first-hand user reports and are not clinical outcomes. Talk to a doctor before starting, stopping or combining anything. How we rate